» Articles » PMID: 38733555

The Impact of Terminal Peptide Extensions of Retinal Inosine 5´Monophosphate Dehydrogenase 1 Isoforms on Their DNA-binding Activities

Overview
Journal Protein J
Publisher Springer
Specialty Biochemistry
Date 2024 May 11
PMID 38733555
Authors
Affiliations
Soon will be listed here.
Abstract

The main structural difference between the mutation-susceptible retinal isoforms of inosine 5´-monophosphate dehydrogenase-1 (IMPDH-1) with the canonical form resides in the C- and N-terminal peptide extensions with unknown structural/functional impacts. In this report, we aimed to experimentally evaluate the functional impact of these extensions on the specific/non-specific single-stranded DNA (ssDNA)-binding activities relative to those of the canonical form. Our in silico findings indicated the possible contribution of the C-terminal segment to the reduced flexibility of the Bateman domain of the enzyme. In addition, the in silico data indicated that the N-terminal tail acts by altering the distance between the tetramers in the concave octamer complex (the native form) of the enzyme. The overall impact of these predicted structural variations became evident, first, through higher K values with respect to either of the substrates relative to the canonical isoform, as reported previously (Andashti et al. in Mol Cell Biochem 465(1):155-164, 2020). Secondary, the binding of the recombinant mouse retinal isoform IMPDH1 (603) to its specific Rhodopsin target gene was significantly augmented while its binding to non-specific ssDNA was lower than that of the canonical isoform. The DNA-binding activity of the other mouse retinal isoform, IMPDH1(546), to specific and non-specific ssDNA was lower than that of the canonical form most probably due to the in silico predicted rigidity created in the Bateman domain by the C-terminal peptide extension. Furthermore, the DNA binding to the Rhodopsin target gene by each of the IMPDH isoforms influenced in the presence of GTP (Guanosine triphosphate) and ATP (Adenosine triphosphate).

References
1.
Bowne S, Sullivan L, Blanton S, Cepko C, Blackshaw S, Birch D . Mutations in the inosine monophosphate dehydrogenase 1 gene (IMPDH1) cause the RP10 form of autosomal dominant retinitis pigmentosa. Hum Mol Genet. 2002; 11(5):559-68. PMC: 2585828. DOI: 10.1093/hmg/11.5.559. View

2.
Burrell A, Nie C, Said M, Simonet J, Fernandez-Justel D, Johnson M . IMPDH1 retinal variants control filament architecture to tune allosteric regulation. Nat Struct Mol Biol. 2022; 29(1):47-58. PMC: 9044917. DOI: 10.1038/s41594-021-00706-2. View

3.
Plana-Bonamaiso A, Lopez-Begines S, Fernandez-Justel D, Junza A, Soler-Tapia A, Andilla J . Post-translational regulation of retinal IMPDH1 in vivo to adjust GTP synthesis to illumination conditions. Elife. 2020; 9. PMC: 7176436. DOI: 10.7554/eLife.56418. View

4.
Bateman A . The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem Sci. 1997; 22(1):12-3. DOI: 10.1016/s0968-0004(96)30046-7. View

5.
Labesse G, Alexandre T, Vaupre L, Salard-Arnaud I, Lai Kee Him J, Raynal B . MgATP regulates allostery and fiber formation in IMPDHs. Structure. 2013; 21(6):975-85. DOI: 10.1016/j.str.2013.03.011. View